Search results
Generative AI will be designing new drugs all on its own in the near future
CNBC· 1 day agoThe advances related to AI are taking place within a field of biology that has been increasingly...
Cyber Criminal Jailed For Blackmailing Therapy Patients - Slashdot
Slashdot· 6 days agoOne of Europe's most wanted cyber criminals has been jailed for attempting to blackmail 33,000 people whose confidential therapy notes he stole. From a report: Julius Kivimaki ...
McKesson (MCK) to Report Q4 Earnings: What's in the Cards?
Zacks via Yahoo Finance· 3 hours agoMcKesson's (MCK) fourth-quarter fiscal 2024 results are likely to reflect the solid display by the...
The promise of health chatbots has already failed
Mother Jones· 6 hours agoFight disinformation: Sign up for the free Mother Jones Daily newsletter and follow the news that matters. Not long ago, I noticed a new term trending in social media wellness circles: “certified ...
Cybin advances in depression, anxiety treatments By Investing.com
Investing.com· 2 hours agoCYB003, a deuterated psilocybin analog, has received Breakthrough Therapy Designation (BTD) from the...
US Physical Therapy expands with new acquisitions By Investing.com
Investing.com· 5 days agoU.S. Physical Therapy, Inc. (NYSE: USPH), a prominent national operator of outpatient physical ...
Silence Therapeutics director Alistair Gray retires By Investing.com
Investing.com· 7 days agoSilence Therapeutics plc (NASDAQ:SLN), a biotechnology company specializing in RNA interference...
3 Gene Editing Stocks with the Potential to Make You an Overnight Millionaire
InvestorPlace· 4 days agoPay close attention to gene editing stocks. All in an effort to help treat sickle-cell anemia,...
Lantheus Holdings, Inc. (NASDAQ:LNTH) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 3 days agoLantheus Holdings, Inc. (NASDAQ:LNTH) Q1 2024 Earnings Call Transcript May 2, 2024 Lantheus...
Labcorp gains FDA approval for hemophilia B diagnostic test By Investing.com
Investing.com· 4 days agoLabcorp (NYSE: LH) has announced the FDA approval of its nAbCyte Anti-AAVRh74var HB-FE Assay, a...